Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Lowering of serum uric acid may be an added benefit of SGLT-2 inhibitors. Might it improve outcomes in patients with heart failure with reduced ejection fraction?
Atrial fibrillation and heart failure frequently coexist. But which came first? This brief paper examines possible causal interaction between AF and LVSD.
A new study quantifies the magnitude of the secondary effects of the COVID-19 pandemic on cardiovascular care, highlighting another example of the long-term implications of COVID-19.
With the ease of online searches and new statistical tools we are facing an overwhelming overproduction and dissemination of meta-analyses. How can we gauge their quality and usefulness?
A new analysis reveals that the SGLT2 inhibitor dapagliflozin produces a greater reduction in incident hospitalization for heart failure in obese patients compared with their non-obese counterparts.
Review the mechanisms behind non-steroidal mineralocorticoid receptor antagonists and and their potential role in the treatment of cardiorenal disease.
The recently published results of the ATLANTIS trial contribute important new evidence regarding optimal antithrombotic therapy post-transcatheter aortic valve implantation.
This paper provides a comprehensive review of evidence informing the decision-making process between TAVI and SAVR. What are the key elements for treatment selection in specific populations?
A new study elucidates the inhibitory role of adult T cells on heart regeneration. What therapeutic implications might this hold for heart failure treatment?
This study examined current evidence on the benefits of different therapy sequencing strategies in patients with heart failure with reduced ejection fraction. Are current guidelines suboptimal?
From the legend of Philippides to "soldier's heart" to "athlete's heart"; this historical perspective traces the evolution of the concept of damaging cardiac effects of sports.
While autopsy rates have been steadily declining, this article underscores their importance in providing insights into the natural history of cardiovascular diseases and cardiac-related deaths.
A new study uncovered a circadian rhythm in nuclear receptor gene expression in platelets, revealing the importance of circadian rhythmicity in platelet activation and thrombus formation.
What have we learned about brain injury and cognitive decline in patients with atrial fibrillation? This editorial discusses the results from a recent study.
